Danaher plans an autonomous antibody lab, AHRQ launches $7.95M initiative, and more - Life AI Weekly #89
October 14, 2026 -
Life AI Weekly
Hi there,
Illumina releases SpliceAI2 for rare disease variant research, while Helfie AI and Kenya's Homa Bay County plan a mobile tuberculosis and hypertension screening pilot for 100,000 high risk residents. Funding news includes Healthleap's $38 million raise for hospital record review technology, Vocca's $20 million Series A, and more than $6 million for Sensydia's noninvasive cardiac assessment system, which has not yet received FDA authorization.
This edition also covers AI tools moving into clinical operations, from ophthalmology scheduling and trial prescreening to chart review, referrals, radiology and maternal mental health support. In life sciences, Araceli Biosciences and Ginkgo Bioworks integrate cellular imaging into an autonomous lab, while Suvoda, Triumph Research Intelligence and Veeva Systems expand AI support for clinical trial and R&D workflows.
Illumina releases SpliceAI2 for rare disease variant research, while Helfie AI and Kenya's Homa Bay County plan a mobile tuberculosis and hypertension screening pilot for 100,000 high risk residents. Funding news includes Healthleap's $38 million raise for hospital record review technology, Vocca's $20 million Series A, and more than $6 million for Sensydia's noninvasive cardiac assessment system, which has not yet received FDA authorization.
This edition also covers AI tools moving into clinical operations, from ophthalmology scheduling and trial prescreening to chart review, referrals, radiology and maternal mental health support. In life sciences, Araceli Biosciences and Ginkgo Bioworks integrate cellular imaging into an autonomous lab, while Suvoda, Triumph Research Intelligence and Veeva Systems expand AI support for clinical trial and R&D workflows.
Illumina releases SpliceAI2 for rare disease research
Illumina releases SpliceAI2, an AI model designed to identify disease relevant genetic splice variants. The company reports the model found 17% more relevant variants than other splicing models in a rare disease research dataset. Read more
CureMD Healthcare earns ISO/IEC 42001 AI certification
CureMD Healthcare says its Artificial Intelligence Management System received ISO/IEC 42001:2023 certification following an independent audit. The certification covers its AI products and governance processes, including risk management, security, transparency and human oversight. Read more
Sensydia Raises More Than $6 Million for AI Cardiac Assessment System
Sensydia raises more than $6 million in an oversubscribed round led by Colle Capital Partners, with support from Orlando Health Ventures. The funding will support clinical studies and commercial preparation for its AI based cardiac assessment system, which is not yet authorized by the FDA. Read more
Helio Genomics presents four studies on HelioLiver cancer test
Helio Genomics presented four studies evaluating its AI powered HelioLiver Dx blood test for liver cancer surveillance. The research examined detection after inconclusive imaging, possible earlier signals before tumors are visible, and early stage detection compared with ultrasound. Read more
Assort Health and Nextech develop AI agents for ophthalmology practices
Assort Health and Nextech will develop AI agents for ophthalmology practices, supporting scheduling, referrals and after hours patient access. The companies cite results from DuPage Ophthalmology, where Assort Health handles about 500 patient calls weekly and reportedly reduces call time by more than 60%. Read more
Healthleap raises $38M for AI that flags overlooked hospital illnesses
Healthleap raised $38 million in seed and Series A funding for an AI platform that reviews hospital records to identify patients who may have undiagnosed conditions. The company says its platform is used by more than 50 hospitals and supports clinical review rather than providing diagnoses. Read more
Danaher plans AI powered autonomous lab for antibody discovery
Danaher plans to open an AI powered autonomous laboratory at Abcam, combining AI, robotics and technologies from several Danaher companies to design, build and test antibodies and molecular tools. The company expects the lab to operate at scale in early 2027, targeting discovery speeds up to eight times faster and annual reagent output up to ten times higher. Read more
Lightbeam reports lower costs for Primary Partners Alliance patients
Lightbeam Health Solutions reports that Primary Partners Alliance patients who completed an Annual Wellness Visit had nearly $70 lower per member per month healthcare costs in a one year analysis. The group also recorded fewer readmissions, lower emergency department use, and higher HCC recapture. Read more
DeepSight Technology appoints Scott Huennekens to its board
DeepSight Technology appoints former Volcano Corporation and Verb Surgical CEO Scott Huennekens to its board of directors. The company is developing a Physical AI platform for minimally invasive procedures that combines sensing, ultrasound imaging and AI. Read more
Red Queen Bio appoints Ian Watson as chief government affairs officer
Red Queen Bio appoints Ian Watson as chief government affairs officer. Watson previously held senior chemical, biological, radiological and nuclear defense, biotechnology, and biosecurity roles in the U.S. government. Read more
GenScript and NVIDIA launch AI life sciences startup competition
GenScript Biotech Corporation and NVIDIA launch a global competition for startups using AI in therapeutic discovery and life sciences. Up to six finalists will pitch during JPM Week in January, with credits for GenScript wet lab data and NVIDIA Brev available as prizes. Read more
AHRQ launches $7.95 million healthcare AI initiative
The Agency for Healthcare Research and Quality launches a two part, $7.95 million prize initiative to apply advanced AI to healthcare research and quality improvement. It includes the Clinical Evidence Synthesis Transformation Challenge and a technology sprint using AHRQ healthcare data. Read more
Helfie AI and Homa Bay County agree on 100,000 person TB pilot
Helfie AI and Kenya's Homa Bay County health ministry signed an MOU to pilot mobile tuberculosis and hypertension screening for 100,000 high risk residents. The program will operate across five subcounties. Read more
The Saffron Solution to showcase 50+ ophthalmology apps at AAO 2026
The Saffron Solution will showcase more than 50 integrated, HIPAA compliant ophthalmology applications at AAO 2026 in New Orleans. The platform connects scheduling, surgery management, patient engagement, automation and AI assisted workflows without software licensing fees. Read more
Function and Google Health Connect Lab Results With Health Guidance
Function and Google Health will let US users share lab results with the Google Health app in fall 2026. The integration combines more than 160 lab tests, wearable data, and Function Medical Intelligence with guidance from Google Health Coach. Read more
Sopris Capital acquires Blackford Analysis from Bayer
Sopris Capital completed its acquisition of medical imaging AI company Blackford Analysis from Bayer on October 9, 2026. Sopris plans to combine the company with Azra AI, while Blackford Analysis continues to operate separately and support existing customers. Read more
Kindable launches Loved app with daily AI calls for seniors
Kindable launches Loved, an app where its AI assistant, Claire, calls seniors daily to discuss wellness and provide reminders. The app shares summaries and wellness trends with family caregivers, while helping them coordinate care tasks. Read more
Wally raises $25 million for AI dental care platform
Wally raises $25 million in a Series A led by Maveron to expand its subscription dental service from 15 to 100 locations. The company uses AI for dental diagnostics and clinical recommendations, and plans to extend its membership to more US cities. Read more
TRI launches TRIAL.OS for AI clinical trial management
Triumph Research Intelligence launches TRIAL.OS, an AI platform for clinical trial management. It includes applications for risk based quality management, with study teams reviewing outputs under clinical research compliance requirements. Read more
HealthpointCapital Invests in Ospitek Surgical Operations Software
HealthpointCapital invests in Ospitek, a provider of AI and IoT software for surgical operations. The funding will support product development and expansion of its technology, commercial and customer success teams. Read more
Brainomix and Pulmonary Fibrosis Foundation partner on AI lung imaging research
Brainomix and the Pulmonary Fibrosis Foundation will study whether AI based CT analysis can help people with pulmonary fibrosis understand changes in their disease and discuss treatment options with clinicians. The research forms part of the PROGRESS PPF programme, supported by Boehringer Ingelheim. Read more
Stowers Institute scientist joins $28.6 million ARPA-H protein aggregation project
Stowers Institute for Medical Research scientist Randal Halfmann joins the NATIVE-ID project, a $28.6 million ARPA-H effort to predict harmful protein changes associated with neurodegenerative disease. His lab will measure aggregation across 50,000 proteins, initially supporting research into frontotemporal lobar degeneration. Read more
Infinitus launches FieldForce AI agents for pharmaceutical field teams
Infinitus introduces FieldForce, a suite of secure AI agents for pharmaceutical sales representatives and field reimbursement managers. The tools support provider meeting preparation, CRM updates, reimbursement workflows and routing medical questions to appropriate teams. Read more
ADLM to Brief Congress on Healthcare AI Policy
ADLM will hold a Washington briefing on October 13, 2026, covering healthcare AI applications, limitations and five proposed policy changes. Laboratory medicine experts will also present a pediatric health case study. Read more
OpenEvidence and Johns Hopkins Medicine collaborate on medical AI
OpenEvidence and Johns Hopkins Medicine collaborate to develop AI supported medical education and clinical care. The work focuses on clinician training and access to current medical evidence during patient care. Read more
AnX Robotica reports 88.6% lower capsule review time with ProScan AI
AnX Robotica reports FDA submission data showing its NaviCam ProScan AI software reduced average small bowel capsule review time from 33 minutes and 42 seconds to 3 minutes and 50 seconds. The company notes the data comes from an independent study, not a head to head comparison with another recently cleared system. Read more
Lunit and Discovery Life Sciences expand AI tissue analysis
Lunit and Discovery Life Sciences will combine Lunit SCOPE with biospecimen and laboratory services. The partnership will support standardized tissue analysis for biomarker research, clinical studies and drug development. Read more
Verana Health and Bitfount expand ophthalmic trial prescreening partnership
Verana Health and Bitfount will combine ophthalmic imaging and electronic health record data to identify patients who may qualify for ophthalmology clinical trials. The approach, developed with Moorfields Eye Hospital, will provide prescreening results through Verana Trial Connect and Bitfount's on premises application. Read more
Vocca raises $20M Series A for AI phone assistant expansion
Vocca raises a $20 million Series A led by Norrsken VC, bringing its total funding to $25 million. The company plans to expand its AI phone assistant across more communication channels, medical specialties and US practices. Read more
Canary Speech and VillageFor add AI vocal analysis to maternal mental health app
Canary Speech partners with VillageFor to add AI based vocal analysis to the My Village app's voice journaling feature. The tool offers wellness assessments for mothers and is available through an add on and the Village Plus subscription, but does not diagnose mental health conditions. Read more
Veeva Systems to showcase agentic AI at R&D and Quality Summit
Veeva Systems will present agentic AI tools for clinical, regulatory, safety and quality operations at its Boston summit on October 20 to 21, 2026. Eli Lilly, Pfizer, Sanofi and UCB will also discuss work across drug development, trials, manufacturing and quality. Read more
Medsender launches referral software for specialty practices
Medsender launches software that processes incoming referrals, contacts patients through text, email and phone, and records booked appointments in EHR systems. At an Anne Arundel Dermatology location, the referral to appointment conversion rate increased from 10% to 48% in its first month. Read more
MediRoutes launches machine learning ETAs for medical transport scheduling
MediRoutes introduces Predictive ETAs for non emergency medical transportation providers. The feature uses historical GPS data and live traffic to estimate trip times, including loading, securement and facility waiting periods. Read more
Symplr survey finds 40% to 46% of hospital processes remain manual
Symplr's annual Compass Survey finds that 40% to 46% of U.S. hospital and health system respondents still manage key processes manually. Respondents reported spending 86 minutes daily on administrative work that AI could reduce, while 26% said their organization actively enforces a comprehensive AI policy. Read more
Araceli Biosciences integrates Endeavor into Ginkgo Bioworks' Nebula lab
Araceli Biosciences and Ginkgo Bioworks integrated the Endeavor high content imaging system into Ginkgo Bioworks' autonomous Nebula lab in Boston. The system captures and analyzes cellular images in real time to support datasets for drug discovery AI models. Read more
LiminalX partners with Rayos Contra Cancer on AI readiness training
LiminalX will integrate the Human Dimension of its THRIVE platform into Rayos Contra Cancer radiation oncology courses worldwide. The training will help clinical teams assess AI readiness and prepare for responsible AI use. Read more
Apodex offers free AI drug research services to smaller developers
Apodex offers small and midsized biotechnology and pharmaceutical companies free access to AI agents, computing resources and biomedical evidence. The services cover clinical trial forecasting, drug repurposing, reformulation, interaction analysis and safety assessments. Read more
Xtalks to Host Webinar on AI Enabled Antibody Optimization
Xtalks will host a live webinar on October 28, 2026, covering high throughput antibody workflows, purification automation, data integration and AI enabled process optimization. Speakers from Axio BioPharma and GenScript will discuss automation for reducing purification labor and improving process data consistency. Read more
Prologue Medicines appoints Stephen Harrison as chief scientific officer
Prologue Medicines appoints Stephen Harrison to lead its scientific and research strategy, including development of its DELVE machine learning platform and viral protein derived medicines. The company also appoints Jason Silvers and Adrian Rawcliffe to its board. Read more
Suvoda makes Sofia AI available for new clinical trials
Suvoda makes its Sofia AI assistant available for new clinical trials using Suvoda RTSM/IRT or eCOA. The tool supports authorized access to trial data, operational questions and system actions, with user permissions and audit trails. Read more
Stryker invests $400 million in CMR Surgical
Stryker will invest about $400 million in CMR Surgical, gaining an exclusive option to acquire the surgical robotics company. Stryker will also become the exclusive US sales agent for Versius, subject to regulatory approvals and closing conditions. Read more
PhyPal Relaunches Patient Engagement Platform With Conversational AI
PhyPal relaunches its patient engagement platform, combining large language models with clinical workflows for intake, documentation, outcomes tracking and treatment authorization. A California workers' compensation pilot will assess its role in treatment coordination and administrative tasks. Read more
TRI releases OPRA update with AI clinical trial risk assessment
UK based Triumph Research Intelligence releases OPRA 26.2, adding the RiskIQ AI agent for protocol analysis and initial clinical trial risk assessments. Risk managers review AI generated suggestions before they are used in active studies. Read more
Likang Life Sciences to showcase AI powered cancer immunotherapy in Abu Dhabi
Likang Life Sciences will present its AI powered neoantigen discovery platform and personalized cancer immunotherapy pipeline at the Abu Dhabi Future Health Summit, held October 20 to 22. The company will also discuss cancer care and highlight LK101, which received clinical trial authorization in China in 2023 and US FDA IND clearance in 2025. Read more
TAITRA pavilion presents Taiwanese clinical AI in Dallas
The TAITRA Smart Healthcare Pavilion brought ten Taiwanese hospitals and health technology companies to Taiwan Expo USA 2026 in Dallas. Exhibitors presented clinical AI, remote monitoring and rehabilitation technologies as they pursue US partnerships and regulatory approval. Read more
Andor Health adds ThinkAndor to Epic Toolbox for nursing documentation
Andor Health says its ThinkAndor ambient AI tool is now listed in the Epic Toolbox for nursing flowsheets. The tool converts clinical conversations into structured nursing documentation in Epic Rover. Read more
Zivian Health launches Elevate AI chart review tool
Zivian Health launches Elevate, an AI tool for automating clinical chart reviews, reviewer assignments, reminders and audit records. The company says the tool supports requirements in all 50 US states and may reduce review costs compared with manual workflows. Read more
HOPPR and CARPL.ai partner on custom radiology AI models
HOPPR and CARPL.ai partner to give healthcare providers access to foundation models for building and deploying custom radiology AI applications. The companies plan to extend support to additional medical imaging types. Read more
Immunomatics receives $100,000 investment from GenDx co founder
Immunomatics receives a $100,000 investment from Myosotis Investments, founded by GenDx co founder Wietse Mulder. Mulder also joins the AI health technology company as a strategic adviser as it develops machine learning tools for transplant risk assessment. Read more
Gemini Health Partners launches AI advisory for specialty revenue cycles
Gemini Health Partners launches an AI strategy advisory practice for specialty healthcare revenue cycles. The service uses claims and prior authorization data to assess automation opportunities in authorization, medical necessity and denial management workflows. Read more
Pomdoctor outlines AI and remote monitoring healthcare strategy
Pomdoctor, a China-based digital healthcare company, plans to combine AI, wearables, remote patient monitoring and real-world health data to support ongoing care. The strategy focuses particularly on chronic disease management and physician-supported services. Read more
Immorta Bio completes preclinical studies for AI designed senolytic peptide
Immorta Bio completed planned preclinical studies for SenoMune 0257, an AI designed peptide intended to help immune cells remove senescent cells. The company plans to begin clinical development in 2026, with human safety and effectiveness yet to be established. Read more
Emplify Health and Pearl Health partner on AI care for 25,000 Medicare beneficiaries
Emplify Health and Pearl Health will use predictive analytics, financial risk modeling and care workflow tools to support about 25,000 Medicare beneficiaries in Wisconsin and Minnesota. Practice onboarding begins in fall 2026, before the partnership starts on January 1, 2027. Read more
Flo Health and Google Health partner on AI tools for women's health
Flo Health and Google Health announce a multiyear partnership covering AI research, future products and consent based health data syncing from early 2027. The companies say users will provide separate permissions for each type and use of data, which will not be sold or used for advertising. Read more
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 15 Reveleer names Jean-Luc Neptune chief medical officer Oct 15 Tucuvi Joins Microsoft Pegasus Program Oct 15 Zealand Pharma signs AI obesity drug deal worth up to $1.2 billion Oct 15 Benchling Launches Science Foundries for Biotech R&D Oct 15 Waterdrop Says AI Cut Complex Underwriting Time by 80% in 2025Free newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
